Divergent Dynamics and Functions of ERK MAP Kinase Signaling in Development, Homeostasis and Cancer: Lessons from Fluorescent Bioimaging

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Apr 13

PMID 30974867

Citations 15

Authors

Yu Muta

Michiyuki Matsuda

Masamichi Imajo

Affiliations

Soon will be listed here.

Abstract

The extracellular signal-regulated kinase (ERK) signaling pathway regulates a variety of biological processes including cell proliferation, survival, and differentiation. Since ERK activation promotes proliferation of many types of cells, its deregulated/constitutive activation is among general mechanisms for cancer. Recent advances in bioimaging techniques have enabled to visualize ERK activity in real-time at the single-cell level. Emerging evidence from such approaches suggests unexpectedly complex spatiotemporal dynamics of ERK activity in living cells and animals and their crucial roles in determining cellular responses. In this review, we discuss how ERK activity dynamics are regulated and how they affect biological processes including cell fate decisions, cell migration, embryonic development, tissue homeostasis, and tumorigenesis.

Citing Articles

Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets.

Long B, Wang Y, Hao S, Shi G Am J Cancer Res. 2024; 14(9):4633-4651.

PMID: 39417189 PMC: 11477815. DOI: 10.62347/KMWB5164.

Tonic ErbB signaling underlies TGFβ-induced activation of ERK and is required for lens cell epithelial to myofibroblast transition.

VanSlyke J, Boswell B, Musil L Mol Biol Cell. 2024; 35(3):ar35.

PMID: 38170570 PMC: 10916858. DOI: 10.1091/mbc.E23-07-0294.

Requirements for mammalian promoters to decode transcription factor dynamics.

Antwi E, Marrakchi Y, Cicek O, Brox T, Di Ventura B Nucleic Acids Res. 2023; 51(9):4674-4690.

PMID: 37070176 PMC: 10201446. DOI: 10.1093/nar/gkad273.

Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target.

Ivanov A, Alecsa M, Popescu R, Starcea M, Mocanu A, Rusu C Int J Mol Sci. 2023; 24(5).

PMID: 36902091 PMC: 10003692. DOI: 10.3390/ijms24054661.

BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells.

Benito-Leon M, Gil-Redondo J, Perez-Sen R, Delicado E, Ortega F, Gomez-Villafuertes R Front Cell Dev Biol. 2023; 10:1049566.

PMID: 36589747 PMC: 9797830. DOI: 10.3389/fcell.2022.1049566.

References

Greene L, Tischler A . Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976; 73(7):2424-8. PMC: 430592. DOI: 10.1073/pnas.73.7.2424. View

Chang L, Karin M . Mammalian MAP kinase signalling cascades. Nature. 2001; 410(6824):37-40. DOI: 10.1038/35065000. View

WUNDERLICH W, Fialka I, Teis D, Alpi A, Pfeifer A, Parton R . A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J Cell Biol. 2001; 152(4):765-76. PMC: 2195784. DOI: 10.1083/jcb.152.4.765. View

Kao S, Jaiswal R, Kolch W, Landreth G . Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem. 2001; 276(21):18169-77. DOI: 10.1074/jbc.M008870200. View

Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View

Troyer K, Luetteke N, Saxon M, Qiu T, Xian C, Lee D . Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology. 2001; 121(1):68-78. DOI: 10.1053/gast.2001.25478. View

Muller J, Ory S, Copeland T, Piwnica-Worms H, Morrison D . C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol Cell. 2001; 8(5):983-93. DOI: 10.1016/s1097-2765(01)00383-5. View

Germain R . T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002; 2(5):309-22. DOI: 10.1038/nri798. View

Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

10.

Murphy L, Smith S, Chen R, Fingar D, Blenis J . Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol. 2002; 4(8):556-64. DOI: 10.1038/ncb822. View

11.

Rajagopalan H, Bardelli A, Lengauer C, Kinzler K, Vogelstein B, Velculescu V . Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002; 418(6901):934. DOI: 10.1038/418934a. View

12.

Hanafusa H, Torii S, Yasunaga T, Nishida E . Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol. 2002; 4(11):850-8. DOI: 10.1038/ncb867. View

13.

van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A . The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002; 111(2):241-50. DOI: 10.1016/s0092-8674(02)01014-0. View

14.

Brose M, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R . BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002; 62(23):6997-7000. View

15.

Teis D, Wunderlich W, Huber L . Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell. 2002; 3(6):803-14. DOI: 10.1016/s1534-5807(02)00364-7. View

16.

Vial E, Marshall C . Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci. 2003; 116(Pt 24):4957-63. DOI: 10.1242/jcs.00812. View

17.

Matsubayashi Y, Ebisuya M, Honjoh S, Nishida E . ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing. Curr Biol. 2004; 14(8):731-5. DOI: 10.1016/j.cub.2004.03.060. View

18.

Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E . Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell. 2004; 7(1):33-44. DOI: 10.1016/j.devcel.2004.05.019. View

19.

Barber T, Vogelstein B, Kinzler K, Velculescu V . Somatic mutations of EGFR in colorectal cancers and glioblastomas. N Engl J Med. 2004; 351(27):2883. DOI: 10.1056/NEJM200412303512724. View

20.

Ebisuya M, Kondoh K, Nishida E . The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci. 2005; 118(Pt 14):2997-3002. DOI: 10.1242/jcs.02505. View